Blood D-(-)-3-hydroxybutyrate concentrations after oral administration of trioctanoin, trinonanoin, or tridecanoin to newborn rhesus monkeys (Macaca mulatta).
Premature newborn infants are born with limited stores of glycogen and fat. Energy, such as medium-chain triglycerides (MCT), which can spare the use of body protein as metabolic energy, may be beneficial. This study compares MCT containing C8, C9, or C10 fatty acids as oral sources of energy for newborn rhesus monkeys (Macaca mulatta). On day 1 of life, 4 groups of 5 monkeys were given a single dose of water or MCT by nasogastric tube. The dose provided approximately 80% of the expected energy requirement. Plasma C8:0, C9:0, and C10:0 fatty acids and whole-blood D-(-)-3-hydroxybutyrate (3HB) concentrations were measured at 0, 1, and 3 h after dosing. Concentrations of free fatty acids (C8, C9, or C10) and ketone (3HB) increased with time after the dose. At 1 and 3 h, concentrations of C8 and C9 did not differ, but C9 was greater than C10. At 1 h, blood 3HB concentrations due to C8 triglyceride were higher than C9 or C10 (503 versus 174 and 225 μmol/L respectively). As MCT chain length increased from C8 to C10, blood concentration of 3HB decreased. Odd-chain MCT (C9 versus C8) resulted in lower whole-blood ketone (3HB), perhaps due to C9 metabolism or the rate of release or uptake of fatty acids. These results have implications for the use of MCT in nutritional supplements for preterm infants.
Department of Nutritional Sciences, University of Wisconsin, Madison, USA.
Mark A
MA
Tetrick
Frank R
FR
Greer
Norlin J
NJ
Benevenga
D020155:3-Hydroxybutyric Acid / Q000097:blood*; D000284:Administration, Oral; D000818:Animals; D000831:Animals, Newborn / Q000097:blood*; D002210:Caprylates / Q000008:administration & dosage / Q000633:toxicity*; D005230:Fatty Acids, Nonesterified / Q000097:blood; D007659:Ketones / Q000097:blood; D008253:Macaca mulatta / Q000097:blood*; D023382:Toxicity Tests, Acute; D014280:Triglycerides / Q000008:administration & dosage / Q000494:pharmacology / Q000633:toxicity*
D002210:Caprylates; D005230:Fatty Acids, Nonesterified; D007659:Ketones; D014280:Triglycerides; C559070:tridecanoin; C031461:tripelargonin; C003637:tricaprylin; D020155:3-Hydroxybutyric Acid
Nutr Res Rev. 1992 Jan;5(1):115-29
19094316
JPEN J Parenter Enteral Nutr. 1991 Jan-Feb;15(1):37-41
1901106
J Nutr. 1987 Apr;117(4):754-7
3585526
Br Med Bull. 1966 Jan;22(1):34-9
5321812
Am J Clin Nutr. 1991 Dec;54(6):1024-8
1957817
J Anim Sci. 1993 Jul;71(7):1869-74
8349514
J Pediatr. 1993 Dec;123(6):975-82
8229533
Physiol Rev. 1978 Apr;58(2):499-527
417347
J Nutr. 2005 Nov;135(11):2609-15
16251619
J Clin Invest. 1986 Jan;77(1):42-8
3944260
J Nutr. 1992 Nov;122(11):2183-9
1432258
Br Med J. 1964 Feb 1;1(5378):273-5
14080598
Acta Paediatr Scand. 1972 May;61(3):273-8
5021448
Can J Biochem Physiol. 1959 Aug;37(8):911-7
13671378
J Anim Sci. 1994 Jan;72(1):133-8
8138480
Am J Gastroenterol. 1978 Feb;69(2):187-90
96693
Acta Physiol Scand. 1957 Oct 22;40(4):338-43
13478501
J Anim Sci. 1989 Dec;67(12):3340-51
2613580
Physiol Rev. 1980 Jan;60(1):143-87
6986618
Anal Biochem. 1982 Jul 1;123(2):270-5
7125202
Am J Clin Nutr. 1982 Nov;36(5):950-62
6814231
J Pediatr. 1981 Jun;98(6):976-8
6785407
J Child Neurol. 1995 Nov;10 Suppl 2:S25-31
8576565
J Anim Sci. 1995 Jul;73(7):2019-25
7592086
Am J Physiol. 1989 Dec;257(6 Pt 1):L318-30
2692464
Pediatr Res. 1986 Apr;20(4):338-41
3703623
Biol Neonate. 1987;52 Suppl 1:87-96
3327537
Dev Neurosci. 1993;15(3-5):156-64
7805567
J Clin Invest. 1956 Nov;35(11):1291-8
13376722
J Nutr. 1991 May;121(5):605-14
2019870
J Nutr. 1995 Feb;125(2):264-72
7861253
Q J Exp Physiol. 1986 Jul;71(3):361-79
3532162